
    
      Vitamin D-deficient individuals will receive once

        -  double-blind, placebo controlled 100.000 I.U.vitamin D3

        -  intramuscular or subcutaneous

      Blood will be taken over time and

        -  immune cells (T cells, B cells, myeloid antigen presenting cells) are characterized by
           flow-cytometry

        -  vitamin D-metabolites will be monitored
    
  